Examples of 'nicox' in a sentence
Meaning of "nicox"
nicox (noun): A pharmaceutical company known for developing innovative medications and treatments
How to use "nicox" in a sentence
Basic
Advanced
nicox
Nicox to participate at two upcoming investor conferences.
The agreement does not provide for any upfront payment from Nicox.
Nicox to receive majority share of revenue.
Any approval of the NDA triggers a payment in Nicox shares to former Aciex shareholders.
Nicox will also provide a number of transitional services to the new company.
All shareholders will automatically receive 1 new Nicox share in exchange for 5 existing Nicox shares.
Nicox disavows any obligation to correct or to update the information contained in analyst reports.
Vyzulta was licensed on a global basis to Bausch + Lomb from Nicox.
The graph of Nicox is the illustrator of this gap type.
Latanoprostene bunod has been licensed by Nicox to Bausch + Lomb.
NicOx will actively seek to enter into partnerships for naproxcinod.
With 3 partnered programs Nicox & Ocumension have forged a strong partnership in China.
NicOx has the strategic objective of transforming itself into a specialty pharmaceutical company.
Naproxcinod ( nitronaproxen ) is a nonsteroidal anti-inflammatory drug ( NSAID ) developed by the French pharmaceutical company NicOx.
Nicox will continue to work closely with Ora following completion of the acquisition.
See also
PreviousPrevious post, EventsNextNext post, Nicox to re-focus naproxcinod on Duchenne muscular dystrophy.
NicOx also conducted trials specifically looking at the effects of NO on lowering blood pressure.
The presentation will be uploaded on Nicox website www . nicox . com on Wednesday February 13th.
Nicox will update the market in due course on the expected NDA submission date.
Throughout the year, a number of appointments were made at Nicox Pharma, the Company 's European subsidiary.
NicOx did not want treatment but just wanted labeling that showed show an improvement.
Jonathan Birt, on behalf of Nicox.
NicOx has appealed this decision.
To linical deve aceuticals ociated with lation of ce 017, Nicox i ticals, LLC.
Nicox launches commercial operations in Germany.
The presentation will be available on Nicox website ( www . nicox . com ) in “ Presentations & Events ” section.
Nicox establishes commercial operations in Italy through acquisition of Eupharmed.
To date, Nicox has no commercial infrastructure in the US.
Nicox also markets additional products in Italy through its subsidiary Eupharmed.
In the US, Nicox commercialises AdenoPlus ( TM ) to eye care professionals.
NicOx and Ferrer present promising clinical and preclinical results in dermatology.
PreviousPrevious post, Nicox raises €18 million to finance development of its pipelineNextNext post, Shareholder Letter.
Nicox plans to enter into a licensing agreement for commercialization of ZERVIATE in the United States.
In August 2016, Nicox completed the transfer of its European and International commercial operations to VISUfarma.
Nicox strengthens its European and International Operations team and expands its product pipeline.
NicOx signs extension of ophthalmology agreement with Pfizer.
Nicox continues European ophthalmic expansion with acquisition of Doliage in France.
The Nicox shares received by Eupharmed 's shareholder will be subject to certain lock-up provisions.
Nicox signs exclusive license agreement with InSite Vision for AzaSite ® and BromSite ™ in Europe.
Nicox has already launched AdenoPlus ® in the United States.
Nicox exercises option to co promote latanoprostene bunod with Bausch + Lomb in the US.
Nicox has also signed an exclusive distribution agreement for AdenoPlus ® with Nitto Medic in Japan.
Nicox launches AdenoPlus ™ in the United States.
Nicox announces financing of €27 million to support its growth strategy.
Nicox received a non-refundable upfront payment of $6 million upon signature of this agreement.
Nicox expects to launch this family of products directly and through partners from late 2013 onwards.
Nicox is headquartered in France and has more than 130 staff worldwide.
NicOx currently anticipates having sufficient cash to sustain operations until the end of 2010.
Nicox intends to start launching products from this internal range in 2015.
Nicox to receive payment on approval and a share of future revenue from sales of AC-120.
